Composition comprising selenazol or thiazalone derivatives and silver and method of treatment therewith
US11013730B1 · kind B1 · utility
0Cited by
264References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 27, 2018 |
| Grant date | May 25, 2021 |
| Priority date | — |
| Expiry date | Aug 27, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating a prokaryotic infection in an animal or human by administering a pharmaceutically acceptable composition, comprising administering a source of silver ions and a benzoisoselenazol derivative, e.g., an ebselen derivative.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.